{
  "fileType": "ValueSet",
  "name": "OncotypeDxDCISRiskScoreInterpretationVS",
  "namespace": "shr.oncology",
  "fqn": "shr.oncology.OncotypeDxDCISRiskScoreInterpretationVS",
  "description": "Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score",
  "url": "http://standardhealthrecord.org/shr/oncology/vs/#OncotypeDxDCISRiskScoreInterpretationVS",
  "values": [
    {
      "system": "http://standardhealthrecord.org/shr/oncology/cs/#OncotypeDxDCISRiskScoreInterpretationCS",
      "code": "low_risk",
      "description": "Recurrence Score lower than 38: The cancer has a low risk of recurrence. The benefit of chemotherapy is likely to be small and will not outweigh the risks of side effects."
    },
    {
      "system": "http://standardhealthrecord.org/shr/oncology/cs/#OncotypeDxDCISRiskScoreInterpretationCS",
      "code": "intermediate_risk",
      "description": "Recurrence Score of 39 up to and including 54: The cancer has an intermediate risk of recurrence. Itâ€™s unclear whether the benefits of chemotherapy outweigh the risks of side effects."
    },
    {
      "system": "http://standardhealthrecord.org/shr/oncology/cs/#OncotypeDxDCISRiskScoreInterpretationCS",
      "code": "high_risk",
      "description": "Recurrence Score greater than or equal to 55: The cancer has a high risk of recurrence, and the benefits of chemotherapy are likely to be greater than the risks of side effects."
    }
  ]
}